LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 1 of total 1

Search options

Article ; Online: Maintenance of mouse hematopoietic stem cells ex vivo by reprogramming cellular metabolism.

Liu, Xia / Zheng, Hong / Yu, Wen-Mei / Cooper, Todd M / Bunting, Kevin D / Qu, Cheng-Kui

Blood

2015  Volume 125, Issue 10, Page(s) 1562–1565

Abstract: ... metabolic pathways represents an effective new strategy for ex vivo maintenance of HSCs. ... The difficulty in maintaining the reconstituting capabilities of hematopoietic stem cells (HSCs ... reprogrammed cellular metabolism from mitochondrial aerobic metabolism to glycolysis, resulting in a remarkable ...

Abstract The difficulty in maintaining the reconstituting capabilities of hematopoietic stem cells (HSCs) in culture outside of the bone marrow microenvironment has severely limited their utilization for clinical therapy. This hurdle is largely due to the differentiation of long-term stem cells. Emerging evidence suggests that energy metabolism plays an important role in coordinating HSC self-renewal and differentiation. Here, we show that treatment with alexidine dihydrochloride, an antibiotic and a selective inhibitor of the mitochondrial phosphatase Ptpmt1, which is crucial for the differentiation of HSCs, reprogrammed cellular metabolism from mitochondrial aerobic metabolism to glycolysis, resulting in a remarkable preservation of long-term HSCs ex vivo in part through hyperactivation of adenosine 5'-monophosphate-activated protein kinase (AMPK). In addition, inhibition of mitochondrial metabolism and activation of AMPK by metformin, a diabetes drug, also decreased differentiation and helped maintain stem cells in culture. Thus, manipulating metabolic pathways represents an effective new strategy for ex vivo maintenance of HSCs.
MeSH term(s) AMP-Activated Protein Kinases/metabolism ; Aerobiosis/drug effects ; Animals ; Biguanides/pharmacology ; Cell Differentiation/drug effects ; Cells, Cultured ; Cellular Reprogramming/drug effects ; Enzyme Activation/drug effects ; Enzyme Inhibitors/pharmacology ; Glycolysis/drug effects ; Hematopoietic Stem Cells/cytology ; Hematopoietic Stem Cells/drug effects ; Hematopoietic Stem Cells/metabolism ; Hypoglycemic Agents/pharmacology ; Metformin/pharmacology ; Mice ; Oxygen Consumption/drug effects ; PTEN Phosphohydrolase/antagonists & inhibitors
Chemical Substances Biguanides ; Enzyme Inhibitors ; Hypoglycemic Agents ; Metformin (9100L32L2N) ; AMP-Activated Protein Kinases (EC 2.7.11.31) ; Ptpmt1 protein, mouse (EC 3.1.3.27) ; PTEN Phosphohydrolase (EC 3.1.3.67) ; alexidine (GVN71CAL3G)
Language English
Publishing date 2015-01-15
Publishing country United States
Document type Journal Article ; Research Support, N.I.H., Extramural
ZDB-ID 80069-7
ISSN 1528-0020 ; 0006-4971
ISSN (online) 1528-0020
ISSN 0006-4971
DOI 10.1182/blood-2014-04-568949
Shelf mark
Uh III Zs.140: Show issues Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular
ab Jg. 2022: Lesesaal (EG)
Zs.MO 364: Show issues
Database MEDical Literature Analysis and Retrieval System OnLINE

More links

Kategorien

To top